BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10320092)

  • 1. Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis.
    Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
    Acta Otolaryngol; 1999 Mar; 119(2):281-4. PubMed ID: 10320092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
    Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
    APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
    Acta Otolaryngol; 1998 Nov; 118(6):887-91. PubMed ID: 9870639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
    Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
    PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Olofsson J
    Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.
    Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo G; June CH; Levine B; Lum LG
    Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1229-34. PubMed ID: 10555694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.
    Heimdal JH; Kross K; Klementsen B; Olofsson J; Aarstad HJ
    BMC Cancer; 2008 Jan; 8():34. PubMed ID: 18234094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
    Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
    Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
    Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
    Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo interleukin (IL)-1 beta, IL-6, IL-12 and tumor necrosis factor-alpha responsiveness with monocytes from patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
    Eur Arch Otorhinolaryngol; 1999; 256(5):250-6. PubMed ID: 10392301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
    Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
    Bergmann C; Strauss L; Wang Y; Szczepanski MJ; Lang S; Johnson JT; Whiteside TL
    Clin Cancer Res; 2008 Jun; 14(12):3706-15. PubMed ID: 18559587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis.
    Wolf GT; Schmaltz S; Hudson J; Robson H; Stackhouse T; Peterson KA; Poore JA; McClatchey KD
    Arch Otolaryngol Head Neck Surg; 1987 Nov; 113(11):1200-6. PubMed ID: 3499156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease.
    Trellakis S; Bruderek K; Dumitru CA; Gholaman H; Gu X; Bankfalvi A; Scherag A; Hütte J; Dominas N; Lehnerdt GF; Hoffmann TK; Lang S; Brandau S
    Int J Cancer; 2011 Nov; 129(9):2183-93. PubMed ID: 21190185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma.
    Young MR; Neville BW; Chi AC; Lathers DM; Boyd Gillespie M; Day TA
    Cancer Immunol Immunother; 2007 Jul; 56(7):1077-86. PubMed ID: 17096152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.
    Chakraborty K; Bose A; Pal S; Sarkar K; Goswami S; Ghosh D; Laskar S; Chattopadhyay U; Baral R
    Int Immunopharmacol; 2008 Feb; 8(2):330-40. PubMed ID: 18182249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
    Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
    Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
    Prince MEP; Zhou L; Moyer JS; Tao H; Lu L; Owen J; Etigen M; Zheng F; Chang AE; Xia J; Wolf G; Wicha MS; Huang S; Ren X; Li Q
    Oral Oncol; 2016 Aug; 59():30-42. PubMed ID: 27424180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.